Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
This Underrated Italian City Boasts Indulgent Food & Captivating Views For A Romantic Escape - 2Figure out how to Keep up with Your Dental Inserts for Long haul Achievement
- 3A Manual for Pick High Evaluated Food Conveyance Administrations In Significant Urban communities For 2024
- 4Surveys of 6 Hot Savvy Beds
- 5Step by step instructions to Protect Your Speculations with Cd Rates
- NASA says Maven spacecraft that was orbiting Mars has gone silent
- Step by step instructions to Involve Compact disc Rates for Magnanimous Giving
- Are IDF reservists properly armed during post-war operations?
- Really focusing on Succulents: Tips and Procedures
- How did life begin on Earth? New experiments support 'RNA world' hypothesis
- The most effective method to Keep up with Proficient Handshakes in a Computerized World
- Hubble Space Telescope spies dusty debris from two cosmic collisions
- 15 Outrageous Cosplay Outfits That Will Blow You Away
- From Certificate to Dollars: College Majors with Extraordinary Monetary Prizes
